1. Home
  2. VTAK vs ISPC Comparison

VTAK vs ISPC Comparison

Compare VTAK & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • ISPC
  • Stock Information
  • Founded
  • VTAK 2002
  • ISPC 2009
  • Country
  • VTAK United States
  • ISPC United States
  • Employees
  • VTAK N/A
  • ISPC N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • ISPC Precision Instruments
  • Sector
  • VTAK Health Care
  • ISPC Health Care
  • Exchange
  • VTAK Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • VTAK 3.1M
  • ISPC 3.1M
  • IPO Year
  • VTAK 2018
  • ISPC 2021
  • Fundamental
  • Price
  • VTAK $0.24
  • ISPC $1.03
  • Analyst Decision
  • VTAK
  • ISPC
  • Analyst Count
  • VTAK 0
  • ISPC 0
  • Target Price
  • VTAK N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • VTAK 41.3M
  • ISPC 46.8K
  • Earning Date
  • VTAK 08-13-2025
  • ISPC 08-05-2025
  • Dividend Yield
  • VTAK N/A
  • ISPC N/A
  • EPS Growth
  • VTAK N/A
  • ISPC N/A
  • EPS
  • VTAK N/A
  • ISPC N/A
  • Revenue
  • VTAK $481,000.00
  • ISPC $8,058,631.00
  • Revenue This Year
  • VTAK $822.86
  • ISPC $35.93
  • Revenue Next Year
  • VTAK $168.42
  • ISPC N/A
  • P/E Ratio
  • VTAK N/A
  • ISPC N/A
  • Revenue Growth
  • VTAK 9.57
  • ISPC N/A
  • 52 Week Low
  • VTAK $0.16
  • ISPC $0.86
  • 52 Week High
  • VTAK $4.76
  • ISPC $11.80
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 45.34
  • ISPC 39.22
  • Support Level
  • VTAK $0.22
  • ISPC $0.95
  • Resistance Level
  • VTAK $0.25
  • ISPC $1.04
  • Average True Range (ATR)
  • VTAK 0.02
  • ISPC 0.07
  • MACD
  • VTAK -0.01
  • ISPC 0.01
  • Stochastic Oscillator
  • VTAK 11.79
  • ISPC 20.45

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: